Physician profile
Katherine Smith
NPI 1649613688
$5,119.70
in general payments reported to CMS, 2019-2025
9 companies · $4,984 in 2025
The $4,984 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.90 · 2020: $15.30 · 2021: $43.85 · 2022: $17.89 · 2024: $23.78 · 2025: $4,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $4,800 · Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $4,800.00 |
| Food and Beverage | $207.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgenex LLC | $4,800.00 | 2025 | Renograft, Ardeograft, Vitograft |
| Baxter Healthcare | $148.44 | 2025 | Perclot |
| Medtronic, INC. | $48.56 | 2021-2022 | |
| Gynesonics, INC. | $35.54 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Verrica Pharmaceuticals INC. | $23.78 | 2024 | Ycanth |
| Sanofi Pasteur INC. | $21.43 | 2019 | |
| Allergan, INC. | $15.30 | 2020 | |
| Abbvie INC. | $13.47 | 2019 | |
| Organogenesis INC. | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.